Saturday, July 11, 2026

Drug profile · INN

chlormethine

chlormethine (LEDAGA) is a dna inhibitor. Associated with Lacuna Pharma Pty Ltd.

EMA: approved TGA: approved Antineoplastic and immunomodulating agents (L01) L01AA05
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — chlormethine
Class
Antineoplastic and immunomodulating agents (L01)
Route
Patents
0
Programs
0
Data quality
0.83

Quick answer

chlormethine (LEDAGA) is a dna inhibitor. Associated with Lacuna Pharma Pty Ltd.

Key facts

INN chlormethine
Brand LEDAGA
Mechanism DNA inhibitor
Target DNA
Therapeutic class Antineoplastic and immunomodulating agents (L01)
ATC code L01AA05

Mechanism of action

DNA inhibitor

Primary target: DNA

Approval history

Authority Status Date
EMA approved
TGA approved

Related & competitor drugs

  1. abiraterone acetate Antineoplastic and immunomodulating agents (L02)
  2. acyclovir Human herpesvirus 1 DNA polymerase inhibitor
  3. acyclovir sodium Human herpesvirus 1 DNA polymerase inhibitor
  4. anagrelide Antineoplastic and immunomodulating agents (L01)
  5. apremilast Antineoplastic and immunomodulating agents (L04)
  6. arsenic trioxide Antineoplastic and immunomodulating agents (L01)

Frequently asked questions

What is chlormethine?

chlormethine (LEDAGA) is a dna inhibitor. Associated with Lacuna Pharma Pty Ltd.

What is the brand name for chlormethine?

LEDAGA is a marketed brand name for chlormethine. Check FDA Drugs@FDA for the current US label holder and prescribing information.